| Not Yet Recruiting | Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxi Overweight, Obesity | Phase 1 | 2026-04-08 |
| Recruiting | Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes Obesity | Phase 2 | 2026-03-31 |
| Not Yet Recruiting | A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodi Type 2 Diabetes | Phase 3 | 2026-03-27 |
| Recruiting | Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myelom Multiple Myeloma and Other Plasma Cell Neoplasms | Phase 1 | 2026-03-17 |
| Recruiting | A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Type 2 Diabetes | Phase 3 | 2026-02-24 |
| Recruiting | A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In P Plaque Psoriasis | Phase 3 | 2025-12-26 |
| Not Yet Recruiting | Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidne T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | Phase 4 | 2025-11-30 |
| Recruiting | A Phase 1 Study of HDM2017 in Advanced Solid Tumors Solid Tumors | Phase 1 | 2025-11-18 |
| Recruiting | Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes Obesity & Overweight | Phase 3 | 2025-10-14 |
| Recruiting | A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin Overweight Subject, Healthy Subjects | Phase 1 | 2025-09-24 |
| Recruiting | Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 3 | 2025-08-12 |
| Recruiting | A Study of HDM2020 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2025-08-11 |
| Recruiting | A Study of HDM2012 in Patients With Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2025-08-06 |
| Recruiting | A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma Diffuse Large B Cell Lymphoma (DLBCL) | Phase 1 / Phase 2 | 2025-07-30 |
| Recruiting | A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 3 | 2025-07-14 |
| Recruiting | A Study of HDM2005 in Patients With Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2025-05-29 |
| Recruiting | A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin Type 2 Diabetes | Phase 2 | 2025-04-30 |
| Recruiting | Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control T2DM (Type 2 Diabetes Mellitus) | Phase 4 | 2025-03-29 |
| Not Yet Recruiting | Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults Overweight and Obesity | Phase 3 | 2025-03-28 |
| Recruiting | A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement Hepatic Impairment, Healthy Volunteers | Phase 1 | 2025-03-18 |
| Recruiting | Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus Obesity | Phase 2 | 2025-02-07 |
| Recruiting | Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients Obesity Control | Phase 3 | 2025-01-03 |
| Recruiting | A Study of HDM2006 in Patients With Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2024-12-31 |
| Completed | Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis Atopic Dermatitis (AD) | Phase 3 | 2024-11-21 |
| Recruiting | Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study Plaque Psoriasis | Phase 3 | 2024-11-14 |
| Not Yet Recruiting | A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Hea Healthy Adult Subject, Overweight Subject | Phase 1 | 2024-10-01 |
| Not Yet Recruiting | A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects Healthy Adult Subject | Phase 1 | 2024-10-01 |
| Completed | Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Hea Type 2 Diabetes | Phase 1 | 2024-09-22 |
| Recruiting | A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects Healthy Adult Subject | Phase 1 | 2024-08-27 |
| Not Yet Recruiting | A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects Healthy Adult Subject | Phase 1 | 2024-08-16 |
| Recruiting | A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor Advanced Solid Tumors, Refractory Lymphoma, Relapsed Hematologic Malignancy | Phase 1 | 2024-08-12 |
| Not Yet Recruiting | HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects Glucagon-Like Peptide-1 Receptor Agonists | Phase 1 | 2024-07-28 |
| Not Yet Recruiting | Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults Overweight and Obesity | Phase 2 | 2024-07-15 |
| Completed | To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 2 | 2024-06-27 |
| Completed | Phase Ib Clinical Study of HDM1005 Injection Overweight and Obesity | Phase 1 | 2024-06-20 |
| Completed | Phase Ia Clinical Study of HDM1005 Injection Obesity and Overweight | Phase 1 | 2024-03-19 |
| Completed | Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2023-09-20 |
| Completed | A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants Kidney Diseases, Kidney Injury, Kidney Failure | Phase 3 | 2023-03-02 |
| Unknown | A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian C Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 3 | 2022-08-18 |